A long ‐acting pegylated recombinant human growth hormone (Jintrolong®) in healthy adult subjects: Two single‐dose trials evaluating safety, tolerability and pharmacokinetics

Journal of Clinical Pharmacy and Therapeutics, EarlyView.

Source: Journal of Clinical Pharmacy and Therapeutics - June 30, 2018 Category: Drugs & Pharmacology Authors: Y. Guan BS , F. He PhD , J. Wu MD , L. Zhao PhD , X. Wang PhD , L. Huang AS , G. Zeng AS , B. Ren PhD , J. Chen PhD , X. Liao MD , Z. Ma MD , X. Chen PhD , G. Zhong PhD , M. Huang PhD , X. Zhao MS Source Type: research